GlassScriptPhysician profile
Karen Deshotel
NPI 1326019258
$263,818.79
in general payments reported to CMS, 2019-2025
20 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $154K · 2022: $109K · 2023: $661 · 2024: $362 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.53 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $260,690.29 | 2021-2022 | |
| Genentech USA, INC. | $517.05 | 2022-2023 | Tecentriq, Venclexta |
| Glaxosmithkline, LLC. | $472.00 | 2021-2025 | Ojjaara |
| E.R. Squibb & Sons, L.L.C. | $425.01 | 2022-2025 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $225.85 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $197.82 | 2022 | |
| Adc Therapeutics America, INC. | $121.85 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $120.84 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $115.00 | 2022 | |
| Emd Serono, INC. | $110.53 | 2024 | |
| Agios Pharmaceuticals, INC. | $110.53 | 2023 | Pyrukynd |
| Genentech, INC. | $107.78 | 2024 | Columvi, Lunsumio |
| Amgen INC. | $106.00 | 2022 | |
| Epizyme, INC. | $102.44 | 2021 | |
| Seagen INC. | $100.00 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $99.99 | 2023 | |
| Mirati Therapeutics, INC. | $77.61 | 2023 | Krazati |
| Lilly USA, LLC | $74.88 | 2021 | |
| Exelixis INC. | $24.57 | 2022 | |
| Aveo Pharmaceuticals, INC. | $18.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Deshotel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.